FDA Takes Steps to Make REMS Info Easier to Share

October 8, 2015

FDA is launching a pilot project to integrate Risk Evaluation and Mitigation Strategies (REMS) into Structured Product Label (SPL) format. This will facilitate the sharing of documents and ease the integration of critical information into pharmacy and hospital IT systems.

As with most pilot programs, participation is on a voluntary basis, and open to application holders of drugs with REMS. With the program, FDA intends to “evaluate a potential approach to converting REMS into SPL format and evaluate the usefulness of the REMS information to be provided in SPL format.”

FDA is accepting requests from candidates that meet the qualifications and are interested in participating until December 7, 2015. The program will last for four months, and will take place from October 6, 2015 to February 3, 2016. For more details on the program or how to register, see the announcement in the Federal Register, here.

This pilot program is one of FDA’s four “priority projects,” which were introduced in a July 2013 meeting in an attempt to improve the REMS program.

For the last 35 years, we have been helping our clients achieve successful interactions with the FDA and have established a strong relationship with the Agency over the years.  We have the knowledge and experience you need to develop and submit a successful application.  Contact us today to learn more about our services and how we can help you.



FDA North America

October 8, 2015

Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions

Guidance Document Guidance for Industry and Food and Drug Administration Staff JUNE 2022 This guidance document provides FDA's recommendations on the information, technical performance assessment,...

Read More
Agency Alerts General Regulatory

October 8, 2015

Can Consumers Handle More Quantitative Info in TV Ads? FDA Plans to Find Out…

FDA wants to know how much of the information presented in television advertisements consumers understandGem, and how much more information they could handle. In an effort to answer these questions,...

Read More
Regulatory Sciences

October 8, 2015

Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part I

Each EU Health Authority has published a wide range of information regarding coronavirus, COVID-19, on their websites. In this blog we will try to guide you through all these recommendations and...

Read More